Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden
· Delayed Price · Currency is SEK 1.035
-0.045 (-4.17%)
Mar 9, 2026, 5:15 PM CET
-67.25% (1Y)
| Market Cap | 31.46M |
| Revenue (ttm) | 36.76M |
| Net Income (ttm) | -25.78M |
| Shares Out | 30.40M |
| EPS (ttm) | -0.94 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,363 |
| Average Volume | 38,779 |
| Open | 1.040 |
| Previous Close | 1.080 |
| Day's Range | 1.000 - 1.040 |
| 52-Week Range | 0.972 - 3.500 |
| Beta | 1.22 |
| RSI | 42.32 |
| Earnings Date | Apr 15, 2026 |